Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Refractive Index Determination – V 2.0

Posted on By

Elixir Department: SOP for Refractive Index Determination – V 2.0

Standard Operating Procedure for Refractive Index Determination in Elixir Formulations

Department Elixir Department
SOP No. SOP/ELX/225/2025
Supersedes SOP/ELX/225/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for determining the refractive index of elixir formulations using an Abbe refractometer or digital refractometer, ensuring product identity and quality compliance.

2. Scope

This SOP applies to the Quality Control Department for routine and stability testing of refractive index in elixir formulations as part of in-process control and final product analysis.

3. Responsibilities

  • QC Analyst:
    • Calibrate the instrument, perform the test, and document results.
  • QC Supervisor:
    • Verify calibration status and review analytical data for accuracy.
  • QA Officer:
    • Ensure test compliance and release authorization based on specification adherence.
See also  Elixir Department: SOP for CIP Validation of Mixing Equipment - V 2.0

4. Accountability

The QC Head is accountable for the execution and integrity of refractive index testing. The QA Head is responsible for regulatory compliance and final product disposition.

5. Procedure

5.1 Equipment and Materials

  • Abbe Refractometer or Digital Refractometer
  • Purified Water (for cleaning)
  • Standard
Reference Liquids (e.g., nD = 1.3330 for water)
  • Lint-free tissue or soft cloth
  • 5.2 Calibration

    1. Clean prism surfaces thoroughly before calibration.
    2. Use distilled water or certified calibration standards at 25°C.
    3. Adjust the instrument to read nD = 1.3330 for water at 25°C.
    4. Record calibration details in the calibration logbook.

    5.3 Sample Preparation and Measurement

    1. Bring the elixir sample to room temperature (25 ± 0.5°C).
    2. Apply a few drops of the sample onto the prism surface.
    3. Close the prism cover and allow temperature equilibration (1–2 minutes).
    4. Read the refractive index displayed (for digital) or adjust till sharp boundary (for Abbe) is visible.
    5. Record the observed refractive index to four decimal places (e.g., 1.4125).
    6. Clean the prism after each use with purified water and dry thoroughly.

    5.4 Acceptance Criteria

    1. The refractive index should fall within the approved range stated in the product specification (e.g., 1.4000–1.4200 at 25°C).
    2. Any deviation beyond limits should be investigated and recorded as per deviation control SOP.

    5.5 Documentation

    1. Enter all readings in the Refractive Index Logbook (Annexure-1).
    2. Record temperature, instrument ID, batch number, and analyst signature.
    3. Attach printouts from digital instruments to the Batch Manufacturing Record (BMR) if applicable.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    • nD: Refractive Index at Sodium D-line (589 nm)
    • BMR: Batch Manufacturing Record

    7. Documents

    1. Refractive Index Logbook (Annexure-1)
    2. Instrument Calibration Logbook
    3. Batch Manufacturing Record (BMR)

    8. References

    • USP Chapter <831> – Refractive Index
    • Ph. Eur. 2.2.6 – Refractive Index
    • 21 CFR Part 211.160 – Laboratory Controls

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Refractive Index Logbook

    Date Batch No. Temperature (°C) Observed nD Specification Instrument ID Tested By Verified By
    11/04/2025 ELX-0425-043 25.0 1.4112 1.4000–1.4200 RF-01 Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP Creation QA Head
    11/04/2025 2.0 Added digital refractometer process and verification Method Expansion QA Head
    See also  Elixir Department: SOP for Cleaning Agitator Shafts and Seals - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: SOP for Verification of Analytical Procedures – V 2.0
    Next Post: Analytical Method Development: SOP for Handling and Verification of Blank and Placebo Interference – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version